Furthermore, analysis of NASH patient datasets (GSE48452 and GSE61260) revealed a positive correlation between MLL4 and CCL2 expression (Fig. 3J), highlighting the selective regulatory role of MLL4 on Ccl2. Here, KMT2D is linked to metabolic dysfunction-associated steatohepatitis.